Meghmani Organics Ltd
Meghmani Organics Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
Top 10 Fertilizers & Agrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Meghmani Organics Ltd Q4 FY26 key numbers
- Revenue
- Pigments segment expected to have flat to moderate revenue growth (INR 500-600 crores range) with improving profitability from cost optimization.
As stated in Meghmani Organics Ltd's Q4 FY26 earnings call transcript · published 24 May 2026. Reported figures, not investment advice.
The short version
Significant top-line growth expected over the next 3 to 5 years, driven mainly by the Crop Protection segment with double-digit growth. Management expects significant top-line and bottom-line growth over the next 3 to 5 years, driven primarily by the Crop Protection and Crop Nutrition segments.
From Meghmani Organics Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Significant top-line growth expected over the next 3 to 5 years, driven mainly by the Crop Protection segment with double-digit growth.
- Crop Nutrition segment to see reasonable growth supported by nano fertilizer products like Nano Urea, Nano DAP, Nano NPK, and Nano Zinc.
- Continuous and growing demand for nano-based fertilizers due to fertilizer availability issues and government promotion.
- Pigments segment expected to have flat to moderate revenue growth (INR 500-600 crores range) with improving profitability from cost optimization.
2 more points from Meghmani Organics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Meghmani Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No significant capex planned for FY27; only routine capex of approximately INR 35-40 crores is expected.
- Manufacturing of new nano fertilizer products (Nano DAP, Nano NPK, Nano Zinc) will leverage existing infrastructure at Sanand facility with no additional capex.
- Titanium Dioxide (TiO2) plant operations are temporarily suspended due to commercial unviability; no current capex on this project.
2 more points from Meghmani Organics Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Meghmani Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Meghmani Organics currently has some orders for Nano Urea in the pipeline.
- More orders are expected going forward, indicating a growing demand.
- Orders will reflect in revenues on a quarter-on-quarter basis, varying by market and season.
- Revenue growth from these orders is anticipated across all quarters within the financial year.
2 more points from Meghmani Organics Ltd's call on order book
Create a free account to keep reading this call
Meghmani Organics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹474 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Meghmani Organics Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Rama Phosphates Ltd (Q4 FY26)
Revenue grew by 20% year-on-year (Page 8). Key investor presentation takeaways from Rama Phosphates's Q4 FY26 investor presentation — and how it ranks against s
- Khaitan Chemicals & Fertilizers Ltd (Q4 FY26)
Q4-FY26 Operational Revenue: INR 1,930 million, up 20.1% YoY (from INR 1,607 million in Q4-FY25). Key investor presentation takeaways from Khaitan Chemical's Q4
- Dhansa Labs Ltd (Q4 FY26)
120-140 crores in additional annual revenue upon stabilization, with initial revenue of around Rs. Key concall takeaways from Dhansa Labs's Q4 FY26 earnings…
- Advance Agrolife Ltd (Q4 FY26)
Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Dharmaj CropGood growth2
- Anya Polytech &Good growth1
- M B Agro Prod.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Meghmani Organics Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Meghmani Organics Ltd Q4 FY26 results?
Significant top-line growth expected over the next 3 to 5 years, driven mainly by the Crop Protection segment with double-digit growth. Management expects significant top-line and bottom-line growth over the next 3 to 5 years, driven primarily by the Crop Protection and Crop Nutrition segments.
What is Meghmani Organics Ltd share price analysis?
Meghmani Organics Ltd currently shows a neutral. The stock trades at a P/E of 25.0 with a market cap of ₹1,608 Cr. Investors should review the full earnings analysis for detailed insights.
Is Meghmani Organics Ltd planning capital expenditure?
No significant capex planned for FY27; only routine capex of approximately INR 35-40 crores is expected.
Keep Meghmani Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.